Transforming molecular testing
through pioneering direct-to-PCR technologies
Welcome to Transformative Biotech. We are a startup biotechnology company focused on deploying rapid, highly accurate, robust, direct-to-PCR technologies with the power to transform molecular testing for infectious diseases and cancer.
We are seeking commercialization partners who are in a position to benefit from deploying these disruptive direct-to-PCR technologies.
We are seeking commercialization partners who are looking to deploy this disruptive PCR technology.
We are looking for commercialization partners who share our belief in the transformative potential of this technology. Our partners will find themselves at the forefront of a new and exciting era in PCR, providing customers with game-changing solutions that offer unprecedented speed, precision, and sensitivity.
We welcome any interested parties to contact us for further information on how we can work together to bring this innovative technology to market. With a proven track record of innovation and a deep commitment to excellence, we are confident in our ability to deliver a high-quality, reliable product that can transform the way researchers and scientists approach PCR. Join us in this exciting journey and experience the transformative potential of our next-generation PCR technology first-hand.
NEW YORK – Boulder, Colorado-based Transformative Biotech announced on Thursday that it has acquired extraction-free, direct-to-PCR technologies...
Transformative Biotech Purchases Direct-to-PCR Technologies From Summit Biolabs (Full text as published in PR Newswire)Transformative Biotech
Market-proven technologies in this intellectual property transaction offers many advantages over traditional PCR testing. BOULDER, Colo., May 18,...